Assets in USD of Neuphoria Therapeutics Inc. from Q2 2023 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary
Neuphoria Therapeutics Inc. quarterly Assets history and change rate from Q2 2023 to Q3 2025.
  • Neuphoria Therapeutics Inc. Assets for the quarter ending 30 Sep 2025 was $27,343,913.000, a 19.3% increase year-over-year.
Assets, Quarterly (USD)
Assets, YoY Quarterly Change (%)

Neuphoria Therapeutics Inc. Quarterly Assets (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $27,343,913 +$4,426,706 +19.3% 30 Sep 2025 10-Q 14 Nov 2025
Q2 2025 $28,589,614 +$940,521 +3.4% 30 Jun 2025 10-Q 14 Nov 2025
Q1 2025 $30,713,319 31 Mar 2025 10-Q 20 May 2025
Q4 2024 $18,168,220 31 Dec 2024 10-Q 14 Feb 2025
Q3 2024 $22,917,207 30 Sep 2024 10-Q 14 Nov 2024
Q2 2024 $27,649,093 -$913,855 -3.2% 30 Jun 2024 10-K 29 Sep 2025
Q2 2023 $28,562,948 30 Jun 2023 10-K 30 Sep 2024
* An asterisk sign (*) next to the value indicates that the value is likely invalid.